Author:
Dubin Perry H.,Sclair Seth N.,Rico Rene,Boehme Amelia K.,Chen Emerson Y.,Martin Paul,Lee William M.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference6 articles.
1. Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci. (Epub ahead of print). doi: 10.1007/s10620-014-3294-0 .
2. Chen EY, Sclair SN, Czul F, et al. A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir. Clin Gastroenterol Hepatol. 2013;11:1014.e2–1020.e2.
3. Kanwal F, El-Serag HB. HCV treatment: The unyielding chasm between efficacy and effectiveness. Clin Gastroenterol Hepatol. 2014;12(8):1381–1383.
4. Hezode C, Fontaine H, Dorival C, et al. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 2014;147(1):132.e4–142.e4.
5. Saxena V, Manos M, Yee H, et al. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. Aliment Pharmacol Ther. 2014;39(10):1213–1224.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献